Fragile X syndrome carrier screening accompanied by genetic consultation has clinical utility in populations beyond those recommended by guidelines

ConclusionThese results support the expansion of FXS screening criteria in guidelines.

Source: Molecular Genetics & Genomic Medicine - November 5, 2019 Category: Genetics & Stem Cells Authors: Katherine Johansen Taber, Jeraldine Lim ‐Harashima, Harris Naemi, Jim Goldberg Tags: ORIGINAL ARTICLE Source Type: research